Targeting CRBN With Thalidomide Suppresses Fibrosis After Glaucoma Drainage Surgery Through NF-κB Pathway Inhibition
Investigative Ophthalmology & Visual Science · 2026
DOI: 10.1167/iovs.67.3.48 ↗Kurz gefasst
Fachartikel in der Zeitschrift Investigative Ophthalmology & Visual Science, 2026. Verfasst von Lijun Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi Province, China. Hauptthemen laut MEDLINE: NF-kappa B, Glaucoma, Thalidomide, Glaucoma Drainage Implants. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi Province, China.
- Department of Ophthalmology, Xi'an No. 1 Hospital, First Affiliated Hospital of Northwest University, Xi'an, Shaanxi Province, China.
Zitieren
APA
Wang, L., Li, H., Xiong, L., Sun, C., & Wang, J. (2026). Targeting CRBN With Thalidomide Suppresses Fibrosis After Glaucoma Drainage Surgery Through NF-κB Pathway Inhibition. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.67.3.48
Vancouver
Wang L, Li H, Xiong L, Sun C, Wang J. Targeting CRBN With Thalidomide Suppresses Fibrosis After Glaucoma Drainage Surgery Through NF-κB Pathway Inhibition. Investigative Ophthalmology & Visual Science. 2026. doi:10.1167/iovs.67.3.48
BibTeX
@article{Wang2026,
author = {Wang, Lijun and Li, Hongsong and Xiong, Lei and Sun, Chao and Wang, Jianming},
title = {Targeting CRBN With Thalidomide Suppresses Fibrosis After Glaucoma Drainage Surgery Through NF-κB Pathway Inhibition},
journal = {Investigative Ophthalmology & Visual Science},
year = {2026},
doi = {10.1167/iovs.67.3.48}
}
EUVIMED